There are few times in our lives when science astonishes us – when we suddenly may be able to do something that once seemed out of reach. This is one of those moments.
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen
Our company’s name is derived from the Greek word, Entelia, meaning a situation of excellence; without fault, having all the required elements, qualities or characteristics.
Genome editing makes permanent changes to the genetic code of a cell by correcting, disabling or modifying the DNA.
Cellectis leverages its leadership in gene editing through its flagship technology, TALEN®, which allows the company to create CAR T therapies to bring new
At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases